Karl
Karl’s partner was diagnosed with relapsing-remitting MS in 2006, just after they had got married. They have moved to a flat on one level, close to local amenities and with wheelchair access. Karl sees managing the effects of MS as a partnership between them.
Karl’s partner was diagnosed with relapsing-remitting MS in 2006. They had both noticed that she had become less able to walk long distances and had some bladder problems, little things as Karl calls them, but they didn’t know if they were serious or would go away. The diagnostic process took about a year, including GP appointments and frequent visits to hospital for consultations with neurologists and investigations. The diagnosis was a shock, though not entirely unexpected as they had been looking at information about the symptoms on the internet. The shock was tinged with relief though, because up to that point they had feared it might be something worse.
Initially, treatment was not offered because the symptoms were not so bad’ and the neurologist thought it best to wait because of the possibility of side effects on possible pregnancies. Since 2009, Karl’s partner has been taking Tysabri, a disease-modifying drug, in a monthly dose. They are instructed to look out for particular side effects, but so far there have been none. It is difficult for them to tell if the Tysabri is having any beneficial effect.
They have received support from a local neurological rehabilitation team, a specialist physiotherapist, a counsellor and an MS Nurse, who is often the first point of contact for Karl’s partner when she needs information. Karl’s employers are also understanding of his needs as a carer, permitting him to accompany his partner on monthly hospital visits during work time, for example. They also have a Carers Network, which Karl has not felt in need of up to now, but is reassured that such support is available should he need it.
Although their families are at some distance (Australia and Wales) they are still able to visit both, with careful planning, and are in regular telephone and email contact. Karl describes in detail the process of planning and making a rail journey to Wales, with a wheelchair-user. He also talks about the benefits to them of the Disability Living Allowance, including the helpfulness to non-drivers of subsidised taxi fares.
Karl’s message to health professionals is to give more practical help to people with MS, in addition to emotional support; for example, provision of wheelchairs for emergency use. To carers in a similar situation he says: It’s a partnership. Listen to your partner and anticipate their needs. You need to make more plans, but you can still do things you want to do.’